CLS and Skåne University Hospital enter a clinical trial agreement to evaluate MR-guided Laser Interstitial Thermal Therapy (LITT) for glioblastoma ablation
Clinical Laserthermia Systems AB (publ) (CLS), which develops advanced innovative products for high-precision image guided laser ablation, announces that it has entered into an agreement with Skåne University Hospital to sponsor a clinical trial evaluating the safety and feasibility of magnetic resonance (MR) guided laser interstitial thermal therapy (MRgLITT) for ablation of glioblastoma lesions, using the CLS TRANBERG® Thermal Therapy System with Thermoguide™ Workstation. Approval for this trial has been obtained from the Swedish Medical